Pandemics

Li Fi Market to grow by USD 4.98 Billion during 2021-2025, Acuity Brands Inc. and General Electric Co. emerge as Key Contributors to growth | Technavio

Retrieved on: 
Wednesday, May 26, 2021
Contemporary history, Health, Articles, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • The COVID-19 pandemic continues to transform the growth of various industries, however,the immediate impact of the outbreak is varied.
  • While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities.
  • The market is projected to grow at a CAGR of 67% during the forecast period,
    What is the keychallenge impeding the market growth?

Fraser Institute News Release: High testing rates, hospital beds, and early lockdowns prove crucial to COVID-19 response; later lockdowns deemed ineffective

Retrieved on: 
Wednesday, May 26, 2021
Articles, Health, Occupational safety and health, COVID-19 pandemic, Pandemics, Public Health Emergency of International Concern, COVID-19, COVID-19 pandemic in Africa, Health in Botswana

Global Storm: The Effects of the COVID-19 Pandemic and Responses around the World analyses the responses to and impacts of COVID-19 for nearly 200 countries over the past year.

Key Points: 
  • Global Storm: The Effects of the COVID-19 Pandemic and Responses around the World analyses the responses to and impacts of COVID-19 for nearly 200 countries over the past year.
  • Rates of testing were determined to be critically important with each additional 100,000 tests per million people being associated with 21 fewer COVID-19 deaths per million.
  • Another important factor that reduced COVID-19 mortality rates was the number of hospital beds per 1,000 people.
  • For example, each additional hospital bed per 1,000 people was associated with 31.5 fewer Covid-19 deaths per million population.

DGAP-News: Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers

Retrieved on: 
Wednesday, May 26, 2021
Articles, Health, Global health, Pandemics, Epidemiology, Virus

Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers

Key Points: 
  • Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers
    The issuer is solely responsible for the content of this announcement.
  • The increase mainly resulted from the continued demand in the Company's Carragelose-based virus blockers, especially in comparison to the pre-pandemic Q1 2020.
  • "Our first quarter results are characterized by continued strong demand for Carragelose-based products, which provide a sensible addition to the existing pandemic prevention and treatment armory.
  • Persistent strong demand for Carragelose-based virus blockers propelled Marinomed's revenues in the first quarter.

Global WholeHealth Partners Corp (OTC: GWHP) and AAJ has Partnered Together and Agreed to Open a Facility in the Philippines Under the Name Global Wholehealth Philippines, as Filed in 8k on May 21, 2021

Retrieved on: 
Tuesday, May 25, 2021
Health, Medicine, Zoonoses, Pandemics, Medical tests, COVID-19, Occupational safety and health, Public health, Virus, DiaSorin, COVID-19 testing

Globals WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer is capable of detecting all the current identified SARS-CoV-2 viruses.

Key Points: 
  • Globals WholeHealth Partners Corp (OTC: GWHP) states that the Antibody IgG/IgM tests that they offer is capable of detecting all the current identified SARS-CoV-2 viruses.
  • Now, with the vaccine, Global is offering one of the largest lines of products to fight this virus.
  • Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID.
  • Notably, Global offers 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.

Global Higher Education Leaders Join Everbridge COVID-19: Road to Recovery (R2R) Executive Summit to Discuss the Post-Pandemic Digital Transformation Across Today’s Universities

Retrieved on: 
Monday, May 24, 2021
Software, Mobile, Wireless, Networks, Internet, Data management, Consumer electronics, Technology, Other Education, Continuing, University, Education, Other Technology, Contemporary history, Health, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Infectious diseases

View the full release here: https://www.businesswire.com/news/home/20210524005504/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210524005504/en/
    Global Higher Education Leaders Join Everbridge COVID-19: Road to Recovery Executive Summit to Discuss the Post-Pandemic Digital Transformation Across Todays Universities (Photo: Business Wire)
    Along with nearly every sector of society, COVID-19 has accelerated the digital transformation of higher education, said Dr. John Maeda, Everbridge Chief Experience Officer and panel moderator.
  • The COVID-19 pandemic suddenly and dramatically transformed ways of working, living, and learning on a global level.
  • The field of higher education, in particular, underwent radical changes driven by the need to digitalize education and training in record time.
  • To register for the Everbridge Spring 2021 COVID-19 R2R: The Road to Recovery Symposium, click here .

Best’s Special Report: COVID-19 Pandemic Intensifies Risk in the Gulf Cooperation Council Countries

Retrieved on: 
Thursday, May 20, 2021
Banking, Professional services, Insurance, Finance, Articles, Contemporary history, Foreign relations, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Gulf Cooperation Council

b'Countries in the Gulf Cooperation Council (GCC) region were hit particularly hard during 2020 as they faced the dual economic shocks of commodity price declines and slowdowns in domestic activity stemming from the COVID-19 pandemic.

Key Points: 
  • b'Countries in the Gulf Cooperation Council (GCC) region were hit particularly hard during 2020 as they faced the dual economic shocks of commodity price declines and slowdowns in domestic activity stemming from the COVID-19 pandemic.
  • According to a new AM Best report, the global resurgence should accelerate economic activity in 2021, although varying degrees of political, economic and financial system risk specific to the region and its members leaves a great deal of risk and uncertainty.\nThe new Best\xe2\x80\x99s Special Report, \xe2\x80\x9cPandemic Intensifies Risk in the Gulf Cooperation Council Countries,\xe2\x80\x9d highlights how country risk factors into all AM Best ratings.
  • As part of evaluating country risk, AM Best identifies the various factors within a country that may affect an insurance company directly or indirectly.
  • According to the report, the surge in the COVID-19 virus toward the end of first-quarter 2021 complicates the region\xe2\x80\x99s economic recovery, particularly for countries with lower vaccination rates.

DSS Launches DSS PureAir, Inc. and Makes Investment into Innovative Proactive Air and Surface Purification Solutions Technology from Puradigm LLC

Retrieved on: 
Wednesday, May 19, 2021
Health, Medicine, Bacteriology, Epidemiology, Pandemics, Virus, Zoonoses, Bacteria

These highly energized plasma molecules kill bacteria and viruses by piercing their cell walls, similar to a pin pricking a balloon.

Key Points: 
  • These highly energized plasma molecules kill bacteria and viruses by piercing their cell walls, similar to a pin pricking a balloon.
  • Their results showed that Puradigm\xe2\x80\x99s technology caused a > 99% average reduction in bacterial growth and a 98.5% average reduction in viral infectivity.
  • Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs.
  • He has successfully restructured more than 35 corporations with a combined value of $25 billion.\n'

Integrated Viral Protection Launches Travel Mobile Unit That Kills All Airborne Viruses

Retrieved on: 
Tuesday, May 18, 2021
Health, Infectious diseases, Articles, Global health, Pandemics, Virus, Zoonoses, Airborne transmission, Airborne, Monzer Hourani

b'HOUSTON, May 18, 2021 /PRNewswire/ -- Integrated Viral Protection (IVP) launched a new portable air purifying unit that instantaneously kills COVID-19 and other airborne pathogens.

Key Points: 
  • b'HOUSTON, May 18, 2021 /PRNewswire/ -- Integrated Viral Protection (IVP) launched a new portable air purifying unit that instantaneously kills COVID-19 and other airborne pathogens.
  • "We must invest in the future of clean air technology to avoid shutting the world down again because of a virus.
  • "\nRecently, Hourani received the Award of Excellence from Engineering News-Record for his lifetime achievement in structural engineering, architecture, design and real estate development, and for this breakthrough invention.
  • IVP\'s Biodefense Indoor Air Protection System is proven as the only technology to "catch and kill" COVID-19 (99.999%) and other airborne pathogens instantaneously in a single pass.\nFor more information or to order IVP\'s Travel unit, visit IVPair.com .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/integrated-viral-protection-laun...\n'

International Isotopes Inc. Announces Financial Results for The First Quarter 2021

Retrieved on: 
Tuesday, May 18, 2021
Contemporary history, Health, Time, COVID-19 pandemic, Occupational safety and health, Pandemics

Our net loss for the three months ended March 31, 2021, was $601,152, compared to net loss of $422,494, for the same period in 2020.

Key Points: 
  • Our net loss for the three months ended March 31, 2021, was $601,152, compared to net loss of $422,494, for the same period in 2020.
  • The increase in sales for the period was due to increased demand for Nuclear Medicine imaging products.
  • We believe this was due in part to a decline in the adverse impact of the COVID-19 pandemic upon our customers and clinics.
  • In March 2021, the supplier returned to full production and our full supply of material has been restored to normal.

AIM ImmunoTech Provides First Quarter 2021 Business Update

Retrieved on: 
Tuesday, May 18, 2021
Health, Zoonoses, Medicine, Epidemiology, Pandemics, Virus, COVID-19, Severe acute respiratory syndrome, Cancer

\xe2\x80\x9cWe have established a strong foundation of pre-clinical and clinical data with respect to the development of therapeutics aimed to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19.

Key Points: 
  • \xe2\x80\x9cWe have established a strong foundation of pre-clinical and clinical data with respect to the development of therapeutics aimed to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19.
  • With our solid financial standing, we intend to execute on our corporate strategy and aggressively move forward with our clinical programs that address critical unmet medical needs.
  • We have reached many important milestones, are encouraged by the outlook for AIM and look forward to providing meaningful updates along the way.\xe2\x80\x9d\nPlease refer to the full 10-Q for complete details.
  • Additionally, please refer to AIM\xe2\x80\x99s most recent Company Presentation for updates on ongoing clinical studies.\ntherapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.\n'